title: [Application of pharmacogenomics and other new technologies to drug development].
authors.affiliation: Servicio de Farmacología Clínica, Hospital Universitario de La Princesa, Instituto Teófilo Hernando, Instituto de Investigación Sanitaria Princesa (IP), Madrid, España.
authors.forename: Teresa
authors.initials: T
authors.lastname: Cabaleiro
authors.forename: Rocío
authors.initials: R
authors.lastname: Prieto-Pérez
authors.forename: Dolores
authors.initials: D
authors.lastname: Ochoa
authors.forename: Francisco
authors.initials: F
authors.lastname: Abad-Santos
mesh_terms: D015415:Biomarkers; D001711:Biotransformation / Q000235:genetics; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017277:Drug Approval; D015195:Drug Design; D004353:Drug Evaluation, Preclinical; D004345:Drug Industry / Q000706:statistics & numerical data; D004335:Drug and Narcotic Control / Q000458:organization & administration; D023281:Genomics; D062069:Inventions; D055432:Metabolomics; D058990:Molecular Targeted Therapy; D018579:Patient Selection; D010597:Pharmacogenetics; D057285:Precision Medicine / Q000639:trends; D040901:Proteomics; D056737:Safety-Based Drug Withdrawals; D018401:Sample Size
chemical_list: D015415:Biomarkers